Stoke Therapeutics's total assets for Q4 2025 were $418.43M, an increase of 16.15% from the previous quarter. STOK total liabilities were $65.98M for the fiscal quarter, a 26.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.